help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erbach, G. T.
Right arrow Articles by Bahr, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erbach, G. T.
Right arrow Articles by Bahr, J. M.

Endocrinology, Vol 128, 1352-1358, Copyright © 1991 by Endocrine Society


ARTICLES

Enhancement of in vivo humoral immunity by estrogen: permissive effect of a thymic factor

GT Erbach and JM Bahr
Department of Physiology, University of Illinois, Urbana 61801.

Physiological levels of estrogen enhance humoral immune responses. Several in vitro studies indicate the hormone to have a direct effect on immune cells, and other studies show that estrogen may affect humoral immunity indirectly through the thymus. Therefore, we have conducted experiments to investigate the requirement of the thymus in the enhancement of humoral immune responsiveness by estrogen. In Exp I, adult ovariectomized Lewis rats were thymectomized or sham thymectomized and given estradiol (E2; 0.25 microgram E2 in sesame oil, sc, once every 4 days) or the oil vehicle in a 2 x 2 factorial design, and their antifluorescein responses were followed by enzyme-linked immunosorbant assay across 21 days. Only animals that were thymus intact and given estrogen replacement showed significantly (P less than 0.05) greater serum antifluorescein titers than all other treatments. In Exp II, ovariectomized thymectomized rats were submitted to a 2 x 3 factorial design of oil vehicle or E2 replacement and saline, gelatin, or thymus replacement (thymosin fraction 5; 1 mg/kg in saline, sc). As described above, only the animals receiving both thymosin fraction 5 and E2 replacement displayed antifluorescein titers that were significantly (P less than 0.03) increased over titers of all other treatment groups. These results indicate that the enhancement of in vivo humoral immunity by estrogen requires the thymus, and that a constitutive thymic factor, found in thymosin fraction 5, exerts a permissive influence on the action of E2 outside the thymus to increase a specific humoral immune response.


This article has been cited by other articles:


Home page
Toxicol SciHome page
V. Selvaraj, D. Bunick, C. Finnigan-Bunick, R. W. Johnson, H. Wang, L. Liu, and P. S. Cooke
Gene Expression Profiling of 17{beta}-Estradiol and Genistein Effects on Mouse Thymus
Toxicol. Sci., September 1, 2005; 87(1): 97 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Staples, T. A. Gasiewicz, N. C. Fiore, D. B. Lubahn, K. S. Korach, and A. E. Silverstone
Estrogen Receptor {alpha} Is Necessary in Thymic Development and Estradiol-Induced Thymic Alterations
J. Immunol., October 15, 1999; 163(8): 4168 - 4174.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Huber, J. Kupperman, and M. K. Newell
Hormonal Regulation of CD4+ T-Cell Responses in Coxsackievirus B3-Induced Myocarditis in Mice
J. Virol., June 1, 1999; 73(6): 4689 - 4695.
[Abstract] [Full Text]


Home page
LupusHome page
S A Huber, J Kupperman, and M K Newell
Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression
Lupus, June 1, 1999; 8(5): 384 - 387.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society